Lindbrook Capital’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $13 | Hold |
29
| – | – | ﹤0.01% | 2773 |
|
|
2024
Q4 | $15 | Hold |
29
| – | – | ﹤0.01% | 2767 |
|
|
2024
Q3 | $26 | Hold |
29
| – | – | ﹤0.01% | 2811 |
|
|
2024
Q2 | $29 | Hold |
29
| – | – | ﹤0.01% | 2744 |
|
|
2024
Q1 | $43 | Sell |
29
-1,725
| -98% | -$2.56K | ﹤0.01% | 2625 |
|
|
2023
Q4 | $1.91K | Hold |
1,754
| – | – | ﹤0.01% | 2277 |
|
|
2023
Q3 | $2.07K | Hold |
1,754
| – | – | ﹤0.01% | 2113 |
|
|
2023
Q2 | $2.47K | Hold |
1,754
| – | – | ﹤0.01% | 2067 |
|
|
2023
Q1 | $2.63K | Hold |
1,754
| – | – | ﹤0.01% | 2124 |
|
|
2022
Q4 | $2.05K | Hold |
1,754
| – | – | ﹤0.01% | 2219 |
|
|
2022
Q3 | $2K | Hold |
1,754
| – | – | ﹤0.01% | 2089 |
|
|
2022
Q2 | $3K | Hold |
1,754
| – | – | ﹤0.01% | 1800 |
|
|
2022
Q1 | $3K | Hold |
1,754
| – | – | ﹤0.01% | 1837 |
|
|
2021
Q4 | $4K | Buy |
1,754
+1,725
| +5,948% | +$3.93K | ﹤0.01% | 1581 |
|
|
2021
Q3 | $0 | Hold |
29
| – | – | ﹤0.01% | 1940 |
|
|
2021
Q2 | $0 | Hold |
29
| – | – | ﹤0.01% | 1960 |
|
|
2021
Q1 | $0 | Hold |
29
| – | – | ﹤0.01% | 1903 |
|
|
2020
Q4 | $0 | Hold |
29
| – | – | ﹤0.01% | 1830 |
|
|
2020
Q3 | $0 | Hold |
29
| – | – | ﹤0.01% | 1801 |
|
|
2020
Q2 | $0 | Hold |
29
| – | – | ﹤0.01% | 1819 |
|
|
2020
Q1 | $0 | Hold |
29
| – | – | ﹤0.01% | 1785 |
|
|
2019
Q4 | $0 | Hold |
29
| – | – | ﹤0.01% | 1530 |
|
|
2019
Q3 | $0 | Hold |
29
| – | – | ﹤0.01% | 1483 |
|
|
2019
Q2 | $0 | Hold |
29
| – | – | ﹤0.01% | 1456 |
|
|
2019
Q1 | $0 | Buy |
+29
| New | – | ﹤0.01% | 1457 |
|